Brad A. Bryan

2.8k total citations
63 papers, 2.1k citations indexed

About

Brad A. Bryan is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brad A. Bryan has authored 63 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brad A. Bryan's work include Vascular Tumors and Angiosarcomas (10 papers), Sarcoma Diagnosis and Treatment (8 papers) and Nanoplatforms for cancer theranostics (7 papers). Brad A. Bryan is often cited by papers focused on Vascular Tumors and Angiosarcomas (10 papers), Sarcoma Diagnosis and Treatment (8 papers) and Nanoplatforms for cancer theranostics (7 papers). Brad A. Bryan collaborates with scholars based in United States, China and Canada. Brad A. Bryan's co-authors include Patrìcia A. D'Amore, Dianne Mitchell, Clarissa Amaya, Mingyao Liu, Tony E. Walshe, Magali Saint‐Geniez, Lewis J. Stafford, Yi Cai, Erin B. Dickerson and Alireza Torabi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Brad A. Bryan

63 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brad A. Bryan United States 27 1.2k 487 315 291 274 63 2.1k
Jenny Norlin Sweden 13 1.2k 1.0× 340 0.7× 270 0.9× 231 0.8× 222 0.8× 20 3.0k
Reimar Abraham Italy 10 2.1k 1.7× 461 0.9× 409 1.3× 251 0.9× 137 0.5× 16 3.0k
Yuji Gunji Japan 19 1.3k 1.0× 506 1.0× 138 0.4× 431 1.5× 136 0.5× 40 2.1k
Elisabet Wallgard Sweden 7 2.0k 1.6× 449 0.9× 523 1.7× 421 1.4× 260 0.9× 7 3.8k
Maya H. Nisancioglu Sweden 6 890 0.7× 316 0.6× 226 0.7× 211 0.7× 179 0.7× 7 2.4k
Peter Hein Germany 18 1.2k 1.0× 688 1.4× 218 0.7× 364 1.3× 308 1.1× 34 2.1k
Tara Karnezis Australia 24 1.1k 1.0× 1.4k 2.9× 217 0.7× 265 0.9× 159 0.6× 35 2.6k
Markéta Hermanová Czechia 23 751 0.6× 481 1.0× 120 0.4× 437 1.5× 209 0.8× 122 1.5k
Anita C. Bellail United States 20 1.6k 1.3× 706 1.4× 240 0.8× 664 2.3× 208 0.8× 29 3.0k
Michael Vanlandewijck Sweden 19 1.6k 1.3× 640 1.3× 276 0.9× 398 1.4× 254 0.9× 35 3.0k

Countries citing papers authored by Brad A. Bryan

Since Specialization
Citations

This map shows the geographic impact of Brad A. Bryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad A. Bryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad A. Bryan more than expected).

Fields of papers citing papers by Brad A. Bryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad A. Bryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad A. Bryan. The network helps show where Brad A. Bryan may publish in the future.

Co-authorship network of co-authors of Brad A. Bryan

This figure shows the co-authorship network connecting the top 25 collaborators of Brad A. Bryan. A scholar is included among the top collaborators of Brad A. Bryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad A. Bryan. Brad A. Bryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bryan, Brad A., et al.. (2024). A patient organization perspective: charting the course to a cure for SCN2A-related disorders. PubMed. 5. 931202405–931202405. 2 indexed citations
2.
Varela‐Ramírez, Armando, Erin B. Dickerson, Eddy Pasquier, et al.. (2019). The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer. Biomedical Journal. 42(3). 155–165. 57 indexed citations
3.
Torabi, Alireza, Clarissa Amaya, Frank H. Wians, & Brad A. Bryan. (2017). PD-1 and PD-L1 expression in bone and soft tissue sarcomas. Pathology. 49(5). 506–513. 62 indexed citations
4.
Amaya, Clarissa, Frank H. Wians, Brad A. Bryan, & Alireza Torabi. (2017). Enhanced expression of Programmed cell death 1 (PD-1) protein in benign vascular anomalies. Pathology. 49(3). 292–296. 6 indexed citations
5.
Amaya, Clarissa, Dianne Mitchell, & Brad A. Bryan. (2017). Rho kinase proteins display aberrant upregulation in vascular tumors and contribute to vascular tumor growth. BMC Cancer. 17(1). 485–485. 10 indexed citations
6.
Tran, Dat Q., Dolores Diaz, Alireza Torabi, et al.. (2015). Functional Genomics Analysis Reveals a MYC Signature Associated with a Poor Clinical Prognosis in Liposarcomas. American Journal Of Pathology. 185(3). 717–728. 14 indexed citations
7.
Amaya, Clarissa, Vittal Kurisetty, Alice M. Nyakeriga, et al.. (2014). A genomics approach to identify susceptibilities of breast cancer cells to “fever-range” hyperthermia. BMC Cancer. 14(1). 81–81. 15 indexed citations
8.
Amaya, Clarissa, et al.. (2014). Epithelial cell adhesion molecule is expressed in a subset of sarcomas and correlates to the degree of cytological atypia in leiomyosarcomas. Molecular and Clinical Oncology. 3(1). 31–36. 10 indexed citations
9.
Bryan, Brad A., et al.. (2013). The Genomic Landscape of Pediatric Bone Sarcomas. 1(2). 88–97. 2 indexed citations
10.
11.
Dennstedt, Emily A. & Brad A. Bryan. (2011). siRNA Knockdown of Gene Expression in Endothelial Cells. Methods in molecular biology. 764. 215–222. 5 indexed citations
12.
Mitchell, Dianne & Brad A. Bryan. (2010). Anti‐angiogenic therapy: Adapting strategies to overcome resistant tumors. Journal of Cellular Biochemistry. 111(3). 543–553. 22 indexed citations
13.
D'Amore, Patrìcia A., et al.. (2009). The function of vascular endothelial growth factor. BioFactors. 35(4). 332–337. 87 indexed citations
14.
Bryan, Brad A. & Patrìcia A. D'Amore. (2008). Chapter 16 Pericyte Isolation and Use in Endothelial/Pericyte Coculture Models. Methods in enzymology on CD-ROM/Methods in enzymology. 443. 315–331. 59 indexed citations
15.
Bryan, Brad A. & Patrìcia A. D'Amore. (2007). What tangled webs they weave: Rho-GTPase control of angiogenesis. Cellular and Molecular Life Sciences. 64(16). 2053–2065. 133 indexed citations
16.
Wrighton, Katharine H., Min Liang, Brad A. Bryan, et al.. (2007). Transforming Growth Factor-β-independent Regulation of Myogenesis by SnoN Sumoylation. Journal of Biological Chemistry. 282(9). 6517–6524. 19 indexed citations
17.
Bryan, Brad A., Yi Cai, Katharine H. Wrighton, et al.. (2005). Ubiquitination of RhoA by Smurf1 promotes neurite outgrowth. FEBS Letters. 579(5). 1015–1019. 52 indexed citations
18.
Cai, Yi, Lewis J. Stafford, Brad A. Bryan, Dianne Mitchell, & Mingyao Liu. (2005). G-protein-activated phospholipase C-β, new partners for cell polarity proteins Par3 and Par6. Oncogene. 24(26). 4293–4300. 29 indexed citations
19.
Bryan, Brad A., Vikas Kumar, Lewis J. Stafford, et al.. (2004). GEFT, A Rho Family Guanine Nucleotide Exchange Factor, Regulates Neurite Outgrowth and Dendritic Spine Formation. Journal of Biological Chemistry. 279(44). 45824–45832. 69 indexed citations
20.
Bryan, Brad A., et al.. (2003). Evidence for control of nitrogen metabolism by a START-dependent mechanism in Saccharomyces cerevisiae. Molecular Genetics and Genomics. 271(1). 72–81. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jenny Norlin Breakdown of academic impact, for papers by Reimar Abraham Breakdown of academic impact, for papers by Yuji Gunji Breakdown of academic impact, for papers by Elisabet Wallgard Breakdown of academic impact, for papers by Maya H. Nisancioglu Breakdown of academic impact, for papers by Peter Hein Breakdown of academic impact, for papers by Tara Karnezis Breakdown of academic impact, for papers by Markéta Hermanová Breakdown of academic impact, for papers by Anita C. Bellail Breakdown of academic impact, for papers by Michael Vanlandewijck
Rankless by CCL
2026